Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 156Lung Neoplasms 99Carcinoma, Non-Small-Cell Lung 61Extensive Stage Small Cell Lung Cancer 10Adenocarcinoma of Lung 7Parkinson Disease 4, Autosomal Dominant Lewy Body 5Carcinoma, Small Cell 5Adenocarcinoma, Bronchiolo-Alveolar 5Small Cell Lung Cancer Extensive Stage 4Drug-Related Side Effects and Adverse Reactions 4Small Cell Lung Cancer Limited Stage 3SCLC, Extensive Stage 3SCLC 3Recurrence 3Radiation Injuries 3Neoplasms 3Carcinoma, Ovarian Epithelial 3Thymoma 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2SCLC,Extensive Stage 2Ovarian Neoplasms 2Melanoma 2Limited Stage Small Cell Lung Cancer 2Kidney Neoplasms 2Extensive Small Cell Lung Cancer 2Carcinoma, Neuroendocrine 2Breast Neoplasms 2

Interventions

Cisplatin 3Surgical Procedures, Operative 2Radiotherapy 2durvalumab 1belinostat 1Vindesine 1S 1 (combination) 1Mitomycin 1Fluorouracil 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancoast Syndrome × Etoposide × Thoracic × Clear all
NCT00984997 2016-06-30

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
38 enrolled
Thoracic

Lung Neoplasms, Pancoast Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡